MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41416-026-03341-0

Медицинская библиотека · British journal of cancer · 2026

Real-world outcomes following adjuvant chemotherapy for resected pancreatic cancer in a centralised oncology service.

Hale Jessica, Gilbert Timothy, Stott Martyn, Whelan Philip, Jackson Richard, Wong Helen, McKay Marie, Ghaneh Paula, Halloran Christopher, Faluyi Olusola, Dunne Declan, Neoptolemos John P, Palmer Daniel

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Pancreatic cancer remains a significant challenge to diagnose and treat, with considerable regional variation in management and outcomes. This study aimed to evaluate real-world outcomes of patients receiving adjuvant treatment for pancreatic cancer at a single centre in Northwest England over an 11-year period.

METHODS

Data were collected retrospectively on all patients who underwent surgery for pancreatic ductal adenocarcinoma between 2009 and 2020. Collected data included patient demographics, surgical details and adjuvant treatment received, including number of chemotherapy cycles and dose reductions.

RESULTS

30-day/inpatient mortality was low (2.4%). Adjuvant chemotherapy delivery rates were high (82%) with 67.4% of patients completing the intended number of cycles. There was no additional survival benefit for patients who started chemotherapy within 8 weeks post-surgery compared to those who began later. Dose reductions did not impact survival, provided patients completed the full course of treatment (mOS 27.5 months vs. 28.5 months; HR 1.14, 95% CI 0.76-1.70 p = 0.513). Following centralisation of care, a greater proportion of patients commenced adjuvant treatment (86% vs 69% p < 0.05).

CONCLUSION

A high proportion of patients received adjuvant treatment, with a centralised clinic model leading to increased rates of adjuvant chemotherapy delivery. Completion of the full chemotherapy course was more critical than dose intensity. Larger prospective studies are needed to investigate the factors contributing to regional variations.

Для цитирования: Hale Jessica, Gilbert Timothy, Stott Martyn, Whelan Philip, Jackson Richard, Wong Helen, McKay Marie, Ghaneh Paula, Halloran Christopher, Faluyi Olusola, Dunne Declan, Neoptolemos John P, Palmer Daniel. Real-world outcomes following adjuvant chemotherapy for resected pancreatic cancer in a centralised oncology service.. British journal of cancer. 2026. DOI: 10.1038/s41416-026-03341-0.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.